An ex vivo lung perfusion system and proprietary perfusate for continuous normothermic perfusion of high-risk donor lungs for up to 4 hours.
Emerging Technology Reports
The Emerging Technology Report provides regular updates about emerging and potentially disruptive technologies that are likely to have a significant impact in healthcare. This “early warning” report monitors new health technologies from 6 months to 2 years within a regulatory submission and tracks those as they go through clinical trial development and the regulatory approval process.
For each emerging technology, our analysts describe the technology and intended use, its prospects relative to the regulatory process and FDA information, competing technologies, relevant clinical guidelines, high-level look at the evidence such as published abstracts in the medical literature and available meeting abstracts, and available clinical trials.
Avastin (Bevacizumab) for Cervical Cancer
Proposed for use in combination with first-line current care chemotherapy for metastatic or recurrent cervical cancer not amenable to curative treatment with surgery and/or radiotherapy.
Imbruvica (Ibrutinib) for Chronic Lymphocytic Leukemia
An oral, once-daily monotherapy for pretreated patients with relapsed or refractory chronic lymphocytic leukemia.
Orbactiv (Oritavancin)
An intravenous semisynthetic lipoglycopeptide antibiotic administered in a 1-dose regimen to treat acute bacterial skin and skin structure infections in adults.
Phasix Mesh for Hernia Repair
A monofilament, fully resorbable surgical mesh for abdominal hernia repair intended as an alternative to biologic mesh.
Sovaldi (Sofosbuvir) Plus Ledipasvir All-Oral Therapy for HCV Genotype 1 Infection
A once-daily, all-oral combination pill for the treatment of hepatitis C virus genotype 1.
Daclatasvir Plus Asunaprevir All-Oral Regimen for HCV Genotype 1 Infection
An all-oral regimen to treat hepatitus C virus genotype 1b infection.
Acessa System
A device to perform minimally invasive radiofrequency ablation of uterine fibroids under laparoscopic ultrasound guidance.
Adasuve (Inhaled Formulation of Loxapine)
Inhaled loxapine for the treatment of acute agitation associated with adult bipolar I disorder or schizophrenia.
Cyramza (Ramucirumab)
An intravenous angiogenesis inhibitor for second-line treatment of advanced gastric or gastroesophageal junction cancer.